We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A dispute at the World Trade Organisation (WTO) over US subsidies to cotton farmers could bring retaliation from Brazilian trade officials, who have hinted that possible action could include breaking patents on leading HIV/AIDS treatments.
Spanish drug industry federation Farmaindustria has criticised a draft healthcare bill, which aims to cut pharmaceutical spending in the country, claiming that it will have a negative impact on industry employment and investment.
Nektar Therapeutics (Nasdaq:NKTR) today announced it had agreed to sell $275 million aggregate principal amount of its 3.25% convertible subordinated notes due 2012 to qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended.
Lane Labs -- USA, Inc ("Lane Labs") has finalized its agreement with Fujix, Inc. of Japan to purchase Fujix's Japanese distributor, 3 A Calcium Kabushiki Kaisha ("3A Calcium KK").
With reference to the news item appearing in a leading financial daily titled 'Elder setting up 2 formulation plants', Elder Pharmaceuticals (Q, N,C,F)* Ltd has clarified that it is true that the company plans to set up two formulation plants in Uttaranchal and Himachal Pradesh and one of them is in the advanced stage of implementation.
Roche Holding AG said it expects its Herceptin drug to receive EU approval for the treatment of early stage HER-positive breast cancer within the second half of 2006.
Nabi Biopharmaceuticals (Nasdaq: NABI) today announced that it received a favorable opinion in Europe regarding Orphan Medicinal Product (OMP) designation for Altastaph(TM) (human Staphylococcus aureus immunoglobulin) for the treatment of Staphylococcus aureus bacteremia.
TransTech Pharma, Inc. (TransTech) today announced it had received a milestone payment from its collaboration partner, Novo Nordisk, as a result of progress made with a drug candidate resulting from their collaboration.
The mortality rate for heart disease in the United Arab Emirates (UAE) is expected to rise to between 50% and 60% in the next decade, according to top cardiologists in the country.